Home › Orexigen: Contrave Sales Set New Record- Still Not Enough To Satisfy The Street
 

Keywords :   


Orexigen: Contrave Sales Set New Record- Still Not Enough To Satisfy The Street

2015-09-15 03:32:09| Biotech - Topix.net

Orerxigen understand first hand what it is like to be the leader in a sector and still get the stock beat up. The main reason for that is that despite outpacing the competition in the branded anti-obesity sector, sales are much lower than what is needed to deliver the level of revenue that will impress the street.

Tags: to the set sales

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Atlantic Tropical Weather Outlook
28.09Eastern North Pacific Tropical Weather Outlook
27.09Washington Corner | September 2024
27.09Hurricane Isaac Graphics
27.09Remnants of John Graphics
27.09Remnants of John Forecast Discussion Number 20
27.09Remnants of John Wind Speed Probabilities Number 20
27.09Remnants of John Public Advisory Number 20
More »